IMMUNOHISTOCHEMISTRY IN CHILDHOOD BRAIN-TUMORS - WHAT ARE THE FACTS

被引:8
|
作者
GULLOTTA, F
机构
[1] Institut für Neuropathologie der Universität, Münster, D-4400
关键词
Brain tumors in childhood; Immunohistochemistry;
D O I
10.1007/BF00308484
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the past, contradictory results have been reported concerning the specificity of neuronal or glial cell markers. However, we have investigated this aspect in a large group of more than 550 brain tumors (among them 60 medulloblastomas). These contradictions can easily be explained by considering two basic facts. First, every neoplastic cell population, especially in embryonic tumors, diffusely infiltrates the brain tissue: non-neoplastic cells, intermingled with tumor cells, can therefore give rise to immunohistochemical and histogenetic misinterpretations. Second, different cell markers can be expressed by one and the same cell (e.g., GFAP, NSE, vimentin), making nosological interpretation of the tumor difficult, impossible, or at best rather subjective. Clear-cut marker positivity is mostly found in the differentiated tumors for which the nosological classification is already clear by the usual histological methods. Only synaptophysin seems to be a reliable marker for neurogenic cells. In embryonic brain tumors (so-called PNET), no correlations between the presence of a given cell marker and the biological behavior of the tumor have so far been detected. © 1990 Springer-Verlag.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
  • [21] IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors
    Marta Mellai
    Angela Piazzi
    Valentina Caldera
    Oriana Monzeglio
    Paola Cassoni
    Guido Valente
    Davide Schiffer
    Journal of Neuro-Oncology, 2011, 105
  • [22] Epidermal growth factor receptor (EGFR) expression in childhood brain tumors
    Bodey, B
    Kaiser, HE
    Siegel, SE
    IN VIVO, 2005, 19 (05): : 931 - 941
  • [23] Diagnostic applications of immunohistochemistry to thyroid tumors
    Katoh, R
    Kawaoi, A
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1999, 32 (02) : 165 - 170
  • [24] The impact of immunohistochemistry on the classification of lung tumors
    Pelosi, Giuseppe
    Scarpa, Aldo
    Forest, Fabien
    Sonzogni, Angelica
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (10) : 1105 - 1121
  • [25] Role of Immunohistochemistry in the Diagnosis of Pilomatrical Tumors
    Alnaqshanbandi, Sarah M.
    McAfee, John L.
    Ko, Jennifer S.
    Billings, Steven D.
    Ronen, Shira
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (12) : 1543 - 1550
  • [26] INCREASED LEVELS OF P21(WAF1/CIP1) IN HUMAN BRAIN-TUMORS
    JUNG, JM
    BRUNER, JM
    RUAN, SB
    LANGFORD, LA
    KYRITSIS, AP
    KOBAYASHI, T
    LEVIN, VA
    ZHANG, W
    ONCOGENE, 1995, 11 (10) : 2021 - 2028
  • [27] CELL-KINETICS OF RAT 9L BRAIN-TUMORS DETERMINED BY DOUBLE LABELING WITH IODODEOXYURIDINE AND BROMODEOXYURIDINE
    ASAI, A
    SHIBUI, S
    BARKER, M
    VANDERLAAN, M
    GRAY, JW
    HOSHINO, T
    JOURNAL OF NEUROSURGERY, 1990, 73 (02) : 254 - 258
  • [28] Quantitative Analysis of Immunohistochemistry in Melanoma Tumors
    Lilyquist, Jenna
    White, Kirsten Anne Meyer
    Lee, Rebecca J.
    Philips, Genevieve K.
    Hughes, Christopher R.
    Torres, Salina M.
    MEDICINE, 2017, 96 (15)
  • [29] IMMUNOHISTOCHEMICAL STUDY ON THE DISTRIBUTION OF ALPHA-SUBUNIT AND BETA-SUBUNIT OF S-100 PROTEIN IN BRAIN-TUMORS
    HAYASHI, K
    HOSHIDA, Y
    HORIE, Y
    TAKAHASHI, K
    TAGUCHI, K
    SONOBE, H
    OHTSUKI, Y
    AKAGI, T
    ACTA NEUROPATHOLOGICA, 1991, 81 (06) : 657 - 663
  • [30] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IMMUNOSTAINING AS AN ALTERNATIVE TO BROMODEOXYURIDINE (BRDU) IMMUNOSTAINING FOR BRAIN-TUMORS IN PARAFFIN EMBEDDED SECTIONS
    SASAKI, A
    NAGANUMA, H
    KIMURA, R
    ISOE, S
    NAKANO, S
    NUKUI, H
    SUZUKI, K
    KAWAOI, A
    ACTA NEUROCHIRURGICA, 1992, 117 (3-4) : 178 - 181